Clinical trials
Phase 3 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
924 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 11 |
| 2002 | 9 |
| 2003 | 15 |
| 2004 | 15 |
| 2005 | 35 |
| 2006 | 41 |
| 2007 | 46 |
| 2008 | 41 |
| 2009 | 50 |
| 2010 | 38 |
| 2011 | 31 |
| 2012 | 39 |
| 2013 | 36 |
| 2014 | 34 |
| 2015 | 35 |
| 2016 | 34 |
| 2017 | 37 |
| 2018 | 40 |
| 2019 | 36 |
| 2020 | 44 |
| 2021 | 40 |
| 2022 | 31 |
| 2023 | 49 |
| 2024 | 54 |
| 2025 | 52 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 540 |
| Active, not recruiting | 133 |
| Recruiting | 108 |
| Terminated | 105 |
| Unknown status | 27 |
| Enrolling by invitation | 4 |
| Withdrawn | 4 |
| Suspended | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 84 |
| Novartis Pharmaceuticals | 69 |
| AstraZeneca | 65 |
| GlaxoSmithKline | 46 |
| Merck Sharp & Dohme LLC | 39 |
| Pfizer | 37 |
| Bristol-Myers Squibb | 36 |
| Boehringer Ingelheim | 34 |
| Chinese University of Hong Kong | 34 |
| Amgen | 32 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 84 |
| Breast Neoplasms | 64 |
| Diabetes Mellitus, Type 2 | 51 |
| Carcinoma, Hepatocellular | 34 |
| Neoplasms | 32 |
| Lung Neoplasms | 23 |
| Neoplasm Metastasis | 22 |
| Colorectal Neoplasms | 20 |
| Diabetes Mellitus | 20 |
| Liver Neoplasms | 17 |
Trials
Showing 26 to 50 of 924. Each trial links to its page on Pharma Observatory.
824 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.